Opal Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Opal Wealth Advisors's VRTX Position: Q2 2026 in Review
Opal Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 88% in Q2 2026, buying an estimated $229K and bringing the position to 1,107 shares worth $550K. The position accounts for 0.12% of the portfolio, ranked #88.
Opal Wealth Advisors first reported a position in VRTX in Q1 2024 and has held it in 7 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Opal Wealth Advisors held 1,107 shares of Vertex Pharmaceuticals worth $550K as of Q2 2026.
- Opal Wealth Advisors bought 517 Vertex Pharmaceuticals shares in Q2 2026, an estimated $229K.
- Vertex Pharmaceuticals made up 0.12% of Opal Wealth Advisors's portfolio in Q2 2026, its #88 holding.
- Opal Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.